New Key Statistics Module, Z-Score and F-Score
HKSE:02171 Key Ratios
Market Cap HK$ M | 3,793.49 |
Enterprise Value HK$ M | 2,090.81 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.93 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) HK$ M | -- |
EPS (TTM) HK$ | -1.47 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.54 |
EV-to-EBITDA | -2.58 |
PEG | -- |
Shares Outstanding M | 575.64 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 9.54 |
Current Ratio | 9.55 |
ROA % (ttm) | -29.05 |
ROE % (ttm) | -34.34 |
ROIC % (ttm) | -128.05 |
Dividend Yield % | -- |
Altman Z-Score | -- |
HKSE:02171 Number of Guru Trades
HKSE:02171 Volume of Guru Trades
Gurus Latest Trades with HKSE:02171
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:02171 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CARsgen Therapeutics Holdings Ltd Insider Transactions
No Available Data